대한골관절종양학회지 (The Journal of the Korean bone and joint tumor society)

  • 제16권1호
  • /
  • Pages.27-36
  • /
  • 2010
  • /
  • 1226-4962(pISSN)
  • /
  • 2233-9841(eISSN)
대한근골격종양학회 (The Korean Musculoskeletal Tumor Society)
권호 표지
DOI QR코드

DOI QR Code

미만형 색소 융모 결절성 활액막염의 관혈적 활막 전 절제술 후 경과

Outcomes of Diffuse-Type Pigmented Villonodular Synovitis (PVNS) after Open Total Synovectomy

  • 이모세 (연세대학교 의과대학 정형외과학교실) ;
  • 이수현 (연세대학교 의과대학 정형외과학교실) ;
  • 서진석 (연세대학교 의과대학 영상의학교실) ;
  • 양우익 (연세대학교 의과대학 병리학교실) ;
  • 신규호 (연세대학교 의과대학 정형외과학교실)
  • Lee, Mo-Ses (Department of Orthopeadic Surgery, Yonsei University College of Medicine) ;
  • Lee, Soo-Hyun (Department of Orthopeadic Surgery, Yonsei University College of Medicine) ;
  • Suh, Jin-Suck (Department of Diagnostic Radiology, Yonsei University College of Medicine) ;
  • Yang, Woo-Ik (Department of Pathology, Yonsei University College of Medicine) ;
  • Shin, Kyoo-Ho (Department of Orthopeadic Surgery, Yonsei University College of Medicine)
  • 투고 : 2010.02.11
  • 심사 : 2010.06.10
  • 발행 : 2010.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 색소 융모 결절성 활액막염은 슬관절을 비롯한 주요 관절에서 드물게 발생하는 연부 조직 종양으로서 수술 적 치료 후 재발 빈도가 높은 것으로 알려져 있다. 본 연구에서는 주요 관절에 발생한 미만형 색소 융모 결절성 활액막염에 대한 활막 전 절제술 후 임상 경과를 보고하고, 기존에 발표 된 문헌과 비교 분석하고자 한다. 대상 및 방법: 1994년 2월부터 2006년 3월까지 미만형 색소 융모 결절성 활액막염으로 치료 받은 21예의 환자를 대상으로 하였으며, 발생 부위는 슬관절 14예, 족관절 5예, 견주관절 2예가 있었다. 평균 추시 기간은 5년 5개월이었다(36-157개월). 발생 연령은 평균 34세였으며 남자가 7명, 여자가 14명이었다. 후향적 연구 방법으로 관절 운동 범위 측정을 포함한 정기적인 임상 양상 평가를 하였다. 결과: 총 21예의 미만형 환자 중 1예를 제외 한 전례에서 활막 전 절제술 및 전기소작술을 통한 보강 치료를 시행하였으며, 정기적인 외래경과 관찰 상 재발이 의심되었던 2예에서 재수술 후, 1예에서만 조직학적 재발이 확진 되었다. 활막 전 절제술을 시행하지 못한 1예와, 재발로 재수술 받은 1예에서 술 후 방사선 치료를 시행 하였다. 임상 기능 평가상 술전과 비교하여 모든 부분에서 통계적으로 유의한 호전이 있었다.(p<0.0001). 슬관절에 발생한 병변으로 수술적 치료를 시행 후 관절 운동 장애로 제약이 있던 환자는 2예(총 14예) 있었다. 결론: 최소 3년 이상의 추시 기간 동안 활막 전 절제술 및 전기 소작술을 통한 보강 치료로 호전된 임상 결과 및 낮은 재발율의 치료 효과를 얻을 수 있었다. 잦은 재발과 주요 관절에 발생하여 국소적 침투, 파괴로 기능 장애를 일으키는 미만형 색소 융모 결절성 활액막염에 치료에 있어 적절한 활막 전 절제술이 시행 될 경우 방사선 보강 치료는 제한 된 경우에만 필요할 것이다.

Purpose: Pigmented villonodular synovitis (PVNS) is a rare soft tissue tumor, which usually arises in larger joints, such as the knee. It has a high recurrence rate after surgical treatment. The purpose of this study is to evaluate and analyze the clinical results of diffuse-type pigmented villonodular synovitis cases that were treated with open total synovectomy. Materials and Methods: Between 1994 and 2006, 21 patients who had diffuse-type pigmented villonodular synovitis were selectively reviewed. Among the 21 cases studied, 14 patients presented at the knee, 5 at the ankle, and 2 at the shoulder and elbow. The mean follow up period was 5.5 years (range, 36-157 months). The average age of the patients was 34 years consist of 7 men and 14 women. Clinical outcomes were analyzed retrospectively, including range of motion and complications. Results: Open total synovectomy and adjuvant electrocautrization were done in all cases except one. During the regular follow-up period after the surgery, two patients showed symptoms of recurrence. After re-operation, only one case was pathologically confirmed as a recurrence. The patient who had partial synovectomy and the other patient who had second operation due to recur rence received additional radiation therapy. Clinical outcome scores were improved in every aspect (p<0.0001). 2 out of 14 Patients who had pigmented villonodular synovitis at the knee developed stiff knee after the surgery. Conclusion: After the open total synovectomy with electrocautrization, a low recurrence rate and satisfactory clinical outcome was achieved, observed in a minimum of 3 years of follow-up.

키워드

참고문헌

  1. Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis and tenosynovitis. A discussion of the synovial and bursal equivalents of the tenosynovial lesion commonly denoted as xanthoma, xanthogranuloma, giantcell tumor of myeloplasioma of the tendon sheath, with some consideration of this tendon sheath lesion itself. Arch Pathol. 1941;31:731-65.
  2. Byers PD, Cotton RE, Deacon OW, et al. The diagnosis and treatment of pigmented villonodular synovitis. J Bone Joint Surg Br. 1968;50:290-305.
  3. Granowitz SP, D'Antonio J, Mankin HL. Th e pathogenesis and long-term end results of pigmented villonodular synovitis. Clin Orthop Relat Res. 1976;114:335-51.
  4. Myers BW, Masi AT. Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine (Baltimore). 1980;59:223-38. https://doi.org/10.1097/00005792-198005000-00004
  5. Flandry F, Hughston JC. Pigmented villonodular synovitis. J Bone Joint Surg Am. 1987;69:942-9. https://doi.org/10.2106/00004623-198769060-00026
  6. McMaster PE. Pigmented Villonodular Synovitis with Invasion of Bone: Report of Six Cases. J Bone Joint Surg Am. 1960; 42:1170-83. https://doi.org/10.2106/00004623-196042070-00007
  7. Scott PM. Bone lesions in pigmented villonodular synovitis. J Bone Joint Surg Br. 1968;50:306-11.
  8. Jergesen HE, Mankin HJ, Schiller AL. Diffuse pigmented villonodular synovitis of the knee mimicking primary bone neoplasms. A report of two cases. J Bone Joint Surg Am. 1978; 60:825-9. https://doi.org/10.2106/00004623-197860060-00019
  9. Johansson JE, Ajjoub S, Coughlin LP, Wener JA, Cruess RL. Pigmented villonodular synovitis of joints. Clin Orthop Relat Res. 1982:159-66.
  10. Rao AS, Vigorita VJ. Pigmented villonodular synovitis (giantcell tumor of the tendon sheath and synovial membrane). A review of eighty-one cases. J Bone Joint Surg Am. 1984;66:76-94. https://doi.org/10.2106/00004623-198466010-00012
  11. Schwartz HS, Unni KK, Pritchard DJ. Pigmented villonodular synovitis. a retrospective review of aff ected large joints. Clin Orthop Relat Res. 1989;247:243-55.
  12. Wiss DA. Recurrent villonodular synovitis of the knee. Successful treatment with yttrium-90. Clin Orthop Relat Res. 1982;169:139-44.
  13. Atmore WG, Dahlin DC, Ghormley RK. Pigmented villonodular synovitis; a clinical and pathologic study. Minn Med. 1956;39:196-202.
  14. Jones FE, Soule EH, Coventry MB. Fibrous xanthoma of synovium (giant-cell tumor of tendon sheath, pigmented nodular synovitis). A study of one hundred and eighteen cases. J Bone Joint Surg Am. 1969;51:76-86. https://doi.org/10.2106/00004623-196951010-00005
  15. Flandry FC, Hughston JC, Jacobson KE, Barrack RL, McCann SB, Kurtz DM. Surgical treatment of diffuse pigmented villonodular synovitis of the knee. Clin Orthop Relat Res. 1994; 300:183-92.
  16. Kotwal PP, Gupta V, Malhotra R. Giant-cell tumour of the tendon sheath. Is radiotherapy indicated to prevent recurrence aft er surgery? J Bone Joint Surg Br. 2000;82:571-3. https://doi.org/10.1302/0301-620X.82B4.10328
  17. Chin KR, Barr SJ, Winalski C, Zurakowski D, Brick GW. Treatment of advanced primary and recurrent diffuse pigment ed villonodular synovitis of the knee. J Bone Joint Surg Am. 2002;84A:2192-202.
  18. Bickels J, Isaakov J, Kollender Y, Meller I. Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diff use pigmented villonodular synovitis. J Bone Joint Surg Am. 2008;90:326-8. https://doi.org/10.2106/JBJS.G.00441
  19. Wu CC, Pritsch T, Bickels J, Wienberg T, Malawer MM. Two incision synovectomy and radiation treatment for diff use pigmented villonodular synovitis of the knee with extra-articular component. Knee. 2007;14:99-106. https://doi.org/10.1016/j.knee.2006.10.014
  20. Ogilvie-Harris DJ, McLean J, Zarnett ME. Pigmented villonodular synovitis of the knee. The results of total arthroscopic synovectomy, partial, arthroscopic synovectomy, and arthroscopic local excision. J Bone Joint Surg Am. 1992;74: 119-23. https://doi.org/10.2106/00004623-199274010-00015
  21. Sharma H, Jane MJ, Reid R. Pigmented villonodular synovitis of the foot and ankle: forty years of experience from the Scottish bone tumor registry. J Foot Ankle Surg. 2006;45:329- 36. https://doi.org/10.1053/j.jfas.2006.05.003
  22. Sharma H, Rana B, Mahendra A, Jane MJ, Reid R. Outcome of 17 pigmented villonodular synovitis (PVNS) of the knee at 6 years mean follow-up. Knee. 2007;14:390-4. https://doi.org/10.1016/j.knee.2007.05.007
  23. Bertoni F, Unni KK, Beabout JW, Sim FH. Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol. 1997;21:153-63. https://doi.org/10.1097/00000478-199702000-00004
  24. Oda Y, Takahira T, Yokoyama R, Tsuneyoshi M. Diff use-type giant cell tumor/pigmented villonodular synovitis arising in the sacrum: malignant form. Pathol Int. 2007;57:627-31. https://doi.org/10.1111/j.1440-1827.2007.02150.x
  25. Finis K, Sultmann H, Ruschhaupt M, et al. Analysis of pigmented villonodular synovitis with genome-wide comple mentary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches. Arthritis Rheum. 2006;54:1009-19. https://doi.org/10.1002/art.21641
  26. Layfi eld LJ, Meloni-Ehrig A, Liu K, Shepard R, Harrelson JM. Malignant giant cell tumor of synovium (malignant pigmented villonodular synovitis). Arch Pathol Lab Med. 2000;124:1636-41.
  27. Beguin J, Locker B, Vielpeau C, Souquieres G. Pigmented villonodular synovitis of the knee: results from 13 cases. Arthroscopy. 1989;5:62-4. https://doi.org/10.1016/0749-8063(89)90094-7